Related Experiment Video
Updated: May 22, 2026

Isolation and Characterization of the Murine Uterosacral Ligaments and Pelvic Floor Organs
Published on: March 3, 2023
A study of lukol in leucorrhoea, pelvic inflammatory diseases and dysfunctional uterine bleeding
P V Tewiri1, Neelam, M K Kulkiro
1Ex. Dean and Head, Department of Prasuti Tantra, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Insights
Lukol effectively relieved symptoms for women experiencing leucorrhoea and dysfunctional uterine bleeding. This study assessed its efficacy in improving patient well-being and reducing common gynecological complaints.
Area of Science:
- Gynecology
- Pharmacology
Background:
- Leucorrhoea and dysfunctional uterine bleeding are prevalent gynecological issues causing significant distress.
- These conditions are common in daily gynecological practice.
Purpose of the Study:
- To evaluate the efficacy of Lukol in providing symptomatic relief for leucorrhoea and dysfunctional uterine bleeding.
- To assess the impact of Lukol on patient-reported distress.
Main Methods:
- Sixty cases with leucorrhoea and/or dysfunctional uterine bleeding were investigated.
- Participants received Lukol 2 tablets three times daily.
- Treatment response was assessed after 15 days based on symptomatic improvement.
Main Results:
- Lukol demonstrated efficacy in alleviating symptoms associated with leucorrhoea.
- Lukol showed positive results in managing dysfunctional uterine bleeding.
- Symptomatic improvement was observed in the majority of cases.
Conclusions:
- Lukol is effective for symptomatic relief in patients with leucorrhoea and dysfunctional uterine bleeding.
- The study supports the use of Lukol for managing common gynecological complaints.
- Further research can explore long-term effects and broader applications.
Abstract:
Leucorrhoea and dysfimctional uterine bleeding are very common and significant clinical manifestations seen by the gynecologist in their day-to day practice and these complaints are sufficient to create distress in females. Lukol has shown efficacy in symptomatic relief in these conditions. A total of sixty cases were registered after a complete detailed investigation. Lukol 2 tablets thrice a day were administered and reviewed after 15 days. The response assessed on the basis of symptomatic improvement.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urine Studies II: Urine Culture and Sensitivity Test

